Literature DB >> 17115269

A "two-step" educational approach for patients taking oral anticoagulants does not improve therapy control.

Doris Barcellona1, Paolo Contu, Francesco Marongiu.   

Abstract

BACKGROUND AND
OBJECTIVE: The educational aspect of oral anticoagulant treatment is considered a possible cause of variability in anticoagulation levels. The aim of this prospective study was to investigate whether the time spent in the therapeutic range (TSTR) by patients taking oral anticoagulants could be improved by two different, consecutive educational approaches on the crucial aspects of oral anticoagulant therapy. DESIGN AND METHODS: Between May and June 2004, validated interviews were conducted with 240 patients (128 male and 112 female, mean age 50 +/- 12 years) enrolled in the study. Three months later, the patients were randomly allocated to three groups. A course that focused on the questions in the interview was followed by the first group (n = 80); a brochure containing the correct answers to questions was given to the second (n = 81); nothing was provided for the third (n = 79).
RESULTS: A significant difference was found in the TSTR between the quarters preceding and following the interview. Mean TSTR increase was 13%. Patients that were randomly selected to attend the educational course, read a brochure or do nothing showed similar TSTR percentages in the quarter following the interview. A good control of the anticoagulant therapy (TSTR >70%) was maintained, with no significant variation during the following three-quarters. INTERPRETATION AND
CONCLUSIONS: A two-step educational approach for patients on long-term oral anticoagulation does not improve TSTR percentages in the short term.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17115269     DOI: 10.1007/s11239-006-9027-2

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  20 in total

1.  Oral anticoagulant therapy: should doctors change the way they give patients explanations?

Authors:  Francesco Marongiu
Journal:  Thromb Haemost       Date:  2003-07       Impact factor: 5.249

2.  Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy.

Authors:  S Kumar; J R Haigh; L E Rhodes; S Peaker; J A Davies; B E Roberts; M P Feely
Journal:  Thromb Haemost       Date:  1989-09-29       Impact factor: 5.249

3.  Anticoagulant patient information material is written at high readability levels.

Authors:  C A Estrada; M M Hryniewicz; V B Higgs; C Collins; J C Byrd
Journal:  Stroke       Date:  2000-12       Impact factor: 7.914

4.  Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial.

Authors:  Silvy Laporte; Sara Quenet; Andréa Buchmüller-Cordier; Jacqueline Reynaud; Brigitte Tardy-Poncet; Christine Thirion; Hervé Decousus; Patrick Mismetti
Journal:  Thromb Haemost       Date:  2003-03       Impact factor: 5.249

5.  Seasonal variation of oral anticoagulant effect.

Authors:  C Manotti; R Quintavalla; C Pattacini; M Pini
Journal:  Thromb Haemost       Date:  1994-06       Impact factor: 5.249

6.  Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.

Authors:  G Palareti; N Leali; S Coccheri; M Poggi; C Manotti; A D'Angelo; V Pengo; N Erba; M Moia; N Ciavarella; G Devoto; M Berrettini; S Musolesi
Journal:  Lancet       Date:  1996-08-17       Impact factor: 79.321

7.  Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy).

Authors:  G Palareti; C Manotti; A DAngelo; V Pengo; N Erba; M Moia; N Ciavarella; G Devoto; M Berrettini; N Leali; M Poggi; C Legnani; S Musolesi; S Coccheri
Journal:  Thromb Haemost       Date:  1997-12       Impact factor: 5.249

8.  Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic.

Authors:  S Cortelazzo; G Finazzi; P Viero; M Galli; A Remuzzi; L Parenzan; T Barbui
Journal:  Thromb Haemost       Date:  1993-04-01       Impact factor: 5.249

9.  The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Jack Ansell; Jack Hirsh; Leon Poller; Henry Bussey; Alan Jacobson; Elaine Hylek
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

10.  A method to determine the optimal intensity of oral anticoagulant therapy.

Authors:  F R Rosendaal; S C Cannegieter; F J van der Meer; E Briët
Journal:  Thromb Haemost       Date:  1993-03-01       Impact factor: 5.249

View more
  5 in total

1.  New educational approach for patients on warfarin improves knowledge and therapy control.

Authors:  Alenka Mavri; Nina Ostasevski Fernandez; Anja Kramaric; Katarina Kosmelj
Journal:  Wien Klin Wochenschr       Date:  2015-04-01       Impact factor: 1.704

Review 2.  Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.

Authors:  Danielle E Clarkesmith; Helen M Pattison; Phyo H Khaing; Deirdre A Lane
Journal:  Cochrane Database Syst Rev       Date:  2017-04-05

3.  EDUC'AVK: reduction of oral anticoagulant-related adverse events after patient education: a prospective multicenter open randomized study.

Authors:  Gilles Pernod; José Labarère; Jacqueline Yver; Bernadette Satger; Benoit Allenet; Touffek Berremili; Michèle Fontaine; Guy Franco; Jean Luc Bosson
Journal:  J Gen Intern Med       Date:  2008-06-20       Impact factor: 5.128

4.  Practice nursed-based, individual and video-assisted patient education in oral anticoagulation--protocol of a cluster-randomized controlled trial.

Authors:  Thanh Duc Hua; Stefan Viktor Vormfelde; Manar Abu Abed; Hannelore Schneider-Rudt; Petra Sobotta; Tim Friede; Jean-François Chenot
Journal:  BMC Fam Pract       Date:  2011-04-10       Impact factor: 2.497

5.  Safety relevant knowledge of orally anticoagulated patients without self-monitoring: a baseline survey in primary care.

Authors:  Jean-François Chenot; Thanh Duc Hua; Manar Abu Abed; Hannelore Schneider-Rudt; Tim Friede; Simon Schneider; Stefan Viktor Vormfelde
Journal:  BMC Fam Pract       Date:  2014-05-25       Impact factor: 2.497

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.